article thumbnail

CareDx Launches Two Expanded Indications for AlloSure Testing Services

DAIC

The Transplant Company recently announced that AlloSureis now commercially available for pediatric heart transplant patients of all ages and patients who have received a simultaneous pancreas-kidney (SPK) transplant. 5 As with other organ transplants, the organs are at risk of rejection. Pediatr Transplant.

article thumbnail

AI tools better at predicting heart transplant rejection than standard clinical method, finds study

Medical Xpress - Cardiology

More than 4,500 heart transplants were performed in the U.S. While the lifesaving operation improves the quality of life and longevity for most recipients, organ rejection remains a risk, with acute rejection occurring in up to 32% of recipients within the first year.

article thumbnail

Inside Tufts' record-breaking heart transplant program

Becker's Hospital Review - Cardiology

In 2024, Boston-based Tufts Medical Center performed 70 adult heart transplants, breaking its 2023 record by nine and setting the New England region record for the second year in a row.

article thumbnail

Tufts breaks regional heart transplant record

Becker's Hospital Review - Cardiology

Boston-based Tufts Medical Center broke the New England regional adult heart transplant record with 61 transplants in 2023.

article thumbnail

Arrhythmias in children undergoing orthotopic heart transplantation

Frontiers in Cardiovascular Medicine

Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. Clinical, procedural, and follow-up data were collected and comprehensively analyzed. Results We identified 27 children (66.7%

article thumbnail

Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study

DAIC

The results also showed a significant reduction of 55% in Severe PGD, a more severe complication occurring within the first 24 hours post-transplant, shown to significantly impact long-term survival of heart transplant recipients. utilizing the Paragonix SherpaPak CTS (p=0.022).

article thumbnail

Cedars-Sinai Cardiologist Leads the American Society of Transplantation

DAIC

Jon Kobashigawa, MD, of the Smidt Heart Institute at Cedars-Sinai, is an expert in heart transplantation, heart failure, and other complex cardiac conditions. An expert in diagnosing heart failure, Kobashigawa also is director of the Advanced Heart Disease Division in the Smidt Heart Institute.